NeuroStim TMS opens third Minnesota clinic in Woodbury

NeuroStim TMS has opened a new Woodbury–St. Paul treatment center in Lake Elmo, expanding access to transcranial magnetic stimulation across Minnesota’s eastern Twin Cities. The opening comes as statewide depression diagnoses rise, and the clinic will hold a public open house Nov. 18.

Why it matters: - The new NeuroStim TMS center adds another local option for patients seeking noninvasive depression treatment in the eastern Twin Cities. - The opening lands as Minnesota sees more adults reporting a lifetime depression diagnosis, raising demand for mental health care options. - NeuroStim TMS says the expansion is meant to make advanced depression treatment more accessible across the region.

What happened: - NeuroStim TMS opened its new Woodbury–St. Paul treatment center, its third location in Minnesota. - The clinic is located at 8519 Eagle Point Boulevard, Suite 100, Lake Elmo, MN 55042. - The center will serve patients from Woodbury, St. Paul, Stillwater, Oakdale and nearby communities. - The company will host a public open house on Nov. 18 from 2–6 p.m. - The event is open to clinicians, prospective patients and community members.

The details: - NeuroStim TMS says it has delivered more than 300,000 standard and accelerated TMS treatments since opening its first clinic in 2018. - The company operates in Washington, Arizona and Minnesota. - NeuroStim TMS reports that 71.5% of patients experience significant improvement in depressive symptoms, and 46.4% achieve remission. - Individual results vary. - The Woodbury–St. Paul center will operate under the medical direction of Amit Mohan, MD. - Mohan is a board-certified psychiatrist with more than 20 years of clinical experience. - Mohan has provided TMS treatment since 2017. - His training includes a psychiatry residency at Mayo Clinic, a sleep medicine fellowship at Cleveland Clinic and specialized TMS training at Duke University. - NeuroStim TMS also offers One-Day TMS™, an accelerated program that delivers multiple TMS sessions in a single day. - The company says the program is designed to reduce time in care while expanding treatment options. - TMS uses targeted magnetic pulses to stimulate brain regions involved in mood regulation. - TMS is a noninvasive outpatient option that does not require surgery or anesthesia. - Certain TMS devices are FDA-cleared for depression, OCD and anxiety symptoms accompanying depression. - A clinical evaluation helps determine whether TMS is appropriate for each patient. - Registration for the open house is available at the open-house page. - People can also call (888) 963-9467 or visit NeuroStimTMS.com for more information or to schedule a free consultation.

Between the lines: - Minnesota Department of Health data show the share of adults reporting a lifetime depression diagnosis rose 28% between 2015 and 2024, from 18.9% to 24.2%. - In the seven-county Twin Cities metro, nearly one in four adults reported a depression diagnosis in 2024. - The timing suggests NeuroStim TMS is betting on rising demand for specialty depression care in the metro area. - The company is also leaning on its treatment volume and reported outcomes as it expands into a new local market.

What's next: - NeuroStim TMS will use the Nov. 18 open house to introduce the clinic, treatment protocols and clinical staff. - The company is positioning the site to attract both patients and referring clinicians from across the eastern Twin Cities. - Further growth could follow if demand for TMS continues to rise alongside depression diagnoses in Minnesota.

The bottom line: - NeuroStim TMS is expanding in Minnesota at a time when depression rates are climbing, and the new Woodbury–St. Paul clinic is meant to meet that demand with specialized, outpatient brain stimulation therapy.